Tighe Reardon

Chief Financial Officer, Synthorx, Inc.

Companies

Janux Therapeutics, Inc.Chief financial officer Jun 10, 2021 to Jun 5, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Janux Therapeutics, Inc. JANX3,515,007 shares²$58.3M at $16.60Jun 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 3, 2024Sold 691,525 shares at $54.75 of Janux Therapeutics, Inc.²
Jun 3, 2024Sold 131,196 shares at $54.75 of Janux Therapeutics, Inc.²
Nov 13, 2023Bought 849,854 shares at $5.87 of Janux Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARJanux Therapeutics, Inc., Chief financial officer
2
SEC EDGARJanux Therapeutics, Inc. shares after the filing of Jun 5, 2024
3
SEC EDGARForm 4 filed Nov 15, 2023